文献速递膀胱癌与上尿路尿路上皮癌

转移性尿路上皮癌接受全身化疗患者中膀胱原发肿瘤局部放疗与总生存的关联

Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
PubMed 文献 · Eur Urol Oncol · 2022-03-03

这项回顾性队列分析查询美国国家癌症数据库,纳入新诊断转移性膀胱尿路上皮癌(cT1-4 N0-3 M1)患者,比较单纯化疗(n=4122)与化疗联合膀胱定向放疗(n=337)的总生存。多变量Cox分析显示化疗联合放疗与更好的总生存独立相关(HR 0.70,95%CI 0.62-0.79;P<0.0001),该结果在匹配分析和landmark分析中持续存在。

要点

  • 化疗联合膀胱定向放疗与更好的总生存独立相关(HR 0.70,95%CI 0.62-0.79;P<0.0001)。
  • 该结果在匹配分析和landmark分析中持续存在。
  • 上述发现为假设生成性,受固有混杂因素限制,作者认为有必要开展前瞻性试验评估膀胱放疗在转移性尿路上皮癌中的作用。

核心结论

  • 化疗联合膀胱定向放疗与更好的总生存独立相关(HR 0.70,95%CI 0.62-0.79;P<0.0001),该结果在匹配分析和landmark分析中持续存在。
  • 上述发现为假设生成性,受固有混杂因素限制,作者认为有必要开展前瞻性试验评估膀胱放疗在转移性尿路上皮癌中的作用。

研究设计与样本

  • 回顾性队列分析,查询美国国家癌症数据库,纳入新诊断转移性膀胱尿路上皮癌(cT1-4 N0-3 M1)患者。
  • 比较单纯化疗组(n=4122)与化疗联合膀胱定向放疗组(n=337),并进行多变量Cox比例风险分析、匹配分析和landmark分析。

主要发现

  • 化疗联合膀胱定向放疗与更好的总生存独立相关(HR 0.70,95%CI 0.62-0.79;P<0.0001)。
  • 该结果在匹配分析和landmark分析中持续存在。

局限性

  • 上述发现为假设生成性,受固有混杂因素限制。
  • 作者认为有必要开展前瞻性试验评估膀胱放疗在转移性尿路上皮癌中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There are limited data on the role of local therapy for metastatic urothelial carcinoma of the bladder (mUC). In this retrospective cohort analysis, we queried the National Cancer Data Base for patients with newly diagnosed mUC (cT1-4 N0-3 M1). Overall survival (OS) was compared between treatment with chemotherapy (CT) alone (n = 4122) and CT plus bladder-directed radiation therapy (CT + RT; n = 337). Multivariable Cox proportional-hazards analyses and matching and landmark analyses were performed. CT + RT was independently associated with better OS (hazard ratio 0.70, 95% confidence interval 0.62-0.79; p < 0.0001) and this result persisted in matched and landmark analyses. These findings are hypothesis-generating and limited by inherent confounding factors; however, a prospective trial evaluating the impact of bladder RT in mUC is warranted. PATIENT SUMMARY: For patients with bladder cancer that has already spread to other parts of the body, it is unclear if radiation therapy directed at the primary bladder tumor would provide any improvement in survival. In this study, we found that aggressive radiation therapy directed at the bladder combined with chemotherapy may provide a survival benefit in some patients with metastatic bladder cancer compared to chemotherapy alone.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Fischer-Valuck BW, Patel SA, Brenneman RJ, et al. Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy. Eur Urol Oncol. 2022. PMID: 35249864. doi:10.1016/j.euo.2022.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。